Bixiye
P83-19 Blue Cross Discontinues Vendor Relationship with Magellan
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2019
Natiijooyinka Raadinta
Soo bandhiga 2941 - 2950 ee natiijooyinka 5095
Bixiye
P78-19 Payment Change for all Medicare Supplement Products
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2019
Bixiye
P23R2-19 Updated Bulletin: Alignment of Start Date for Prior Authorization Requests
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2019
Bixiye
P81-19 2020 Renewal Changes Summary for Institutional Providers
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2019
Bixiye
P76-19 CMS Changing Payment Classification System for Home Health Effective January 1, 2020
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2019
Bixiye
P85-19 New Colonoscopy Reimbursement Policy for Commercial Lines of Business
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2019
Bixiye
2019 October Bulletins
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2019
Bixiye
QP85-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Sunosi ™
Taariikhda uu dhaqangalayo barnaamijka: Okt 23, 2019
Bixiye
QP82-19 Pharmacy Benefit Update – New Insulin Zero Copay Initiative for Commercial Lines of Business
Taariikhda uu dhaqangalayo barnaamijka: Okt 23, 2019
Bixiye
QP83-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Egrifta® (tesamorelin)
Taariikhda uu dhaqangalayo barnaamijka: Okt 23, 2019